Oct 27 (Reuters) - Organon said on Monday CEO
Kevin Ali will resign from his role and be replaced by Joseph
Morrissey on an interim basis, after an internal investigation
into wholesaler sales practices for its Nexplanon contraceptive
implant.
(Reporting by Puyaan Singh in Bengaluru; Editing by Devika
Syamnath)